BioSpace News Archive

Mallinckrodt plc announced positive top-line results from its pivotal Phase 3 CONFIRM clinical study evaluating the efficacy and safety of terlipressin in 300 adults with hepatorenal syndrome type 1.

Quest Diagnostics, the world’s leading provider of diagnostic information services, announced that its Board of Directors declared a quarterly cash dividend of $0.53 per share, payable on October 21, 2019 to shareholders of record of Quest Diagnostics common stock on October 4, 2019.

Regen Lab SA (Regenlab) has failed to pay legal costs ordered by the UK High Court after revocation of its PRP patent for lack of novelty and inventive step. Regenlab is exposed to enforcement procedures which may limit its ability to provide products in the marketplace

Soligenix, Inc. announced that the National Institute of Dental and Craniofacial Research, part of the National Institutes of Health, has awarded Soligenix a Phase I Small Business Innovation Research of approximately $150,000 to support the evaluation of SGX942 in pediatric indications.

Phio Pharmaceuticals Corp. announced that is has entered into a research collaboration with the Helmholtz Zentrum München.

Novasec’s platform combines the renewable energy sector with digital securities, providing investors the potential for lower-risk, competitive returns.

Applied BioSciences Corp. announced its financial results for the first quarter Fiscal Year 2020 ended June 30, 2019.

BELLUS Health Inc. announced that it is proceeding with a 3.6:1 consolidation of the Company’s common shares with an effective date of August 19, 2019.

Groundbreaking Invention is the First-Ever to Break Down a Byproduct of Alcohol [15-August-2019] SAN FRANCISCO , Aug. 15, 2019 /PRNewswire/ -- ZBiotics Company (ZBiotics), a genetic engineering company dedicated to creating consumer products that augment our health and improve our everyday lives, today announced the official launch of ZBiotics™, a functional beverag

The members-only 24/7 medical centers and concierge service relaunch with a new identity and a new look